Cherith Campbell-Bell is currently serving as the Director of Clinical Development at Rinri Therapeutics.
Throughout her career, Cherith has focused on advancing innovative treatments through the critical stages of clinical development, with particular expertise in guiding programs from early-phase trials into later-stage studies. She is skilled at designing integrated clinical strategies that align scientific, regulatory, and commercial objectives—ensuring that development plans are both evidence-based and strategically positioned for market authorisation.
As a speaker at Advanced Therapies UK 2026, Cherith will share her insights and expertise on the critical transition from pre-clinical to early clinical development. She will discuss the strategic design and implementation of clinical development plans that not only support first-in-human studies but also lay the groundwork for successful regulatory submissions and market authorisation.